Cas:888327-32-0 4-Bromo-1-(difluoromethoxy)-2-methylbenzene manufacturer & supplier

Chemical Name:4-Bromo-1-(difluoromethoxy)-2-methylbenzene

CAS.NO:888327-32-0

Synonyms:4-bromo-1-(difluoromethoxy)-2-methylbenzene

Molecular Formula:C₈H₇BrF₂O

Molecular Weight:237.04100

HS Code:2909309090

Physical and Chemical Properties:

Melting point:N/A

Boiling point:223ºC

Density:1.508

Index of Refraction:

PSA:9.23000

Exact Mass:235.96500

LogP:3.35890

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like 4-bromo-1-(difluoromethoxy)-2-methylbenzene chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,4-bromo-1-(difluoromethoxy)-2-methylbenzene physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,4-bromo-1-(difluoromethoxy)-2-methylbenzene Use and application,4-bromo-1-(difluoromethoxy)-2-methylbenzene technical grade,usp/ep/jp grade.

Related News: Biogen last month revived its plans to seek U.S. approval for its aducanumab treatment after announcing in March that it would terminate two large clinical trials for the drug. But some analysts believed FDA approval is highly unlikely. 4-Bromo-1-(difluoromethoxy)-2-methylbenzene manufacturer Many domestic raw material pharmaceutical and intermediate manufacturing companies with strong capital and talent reserves and advanced technology and processes have developed in the country, and the competitiveness of market participants has continued to increase. 4-Bromo-1-(difluoromethoxy)-2-methylbenzene supplier Darzalex does have another regimen approved for the same myeloma population. Darzalex combined with Takeda’s Velcade, melphalan and prednisone (VMP) reduced the risk of death by 40% in the phase 3 ALCYONE trial. But disease progression had already occurred in half of patients on the Darzalex-VMP combo after about three years of follow-up, a much shorter period than the five-year mark the Darzalex-Rd regimen is approaching. 4-Bromo-1-(difluoromethoxy)-2-methylbenzene vendor In October 2020, the Trump administration ordered $375 million worth of Lilly’s COVID-19 antibody therapy bamlanivimab, which is manufactured at the Branchburg plant. 4-Bromo-1-(difluoromethoxy)-2-methylbenzene factory Darzalex does have another regimen approved for the same myeloma population. Darzalex combined with Takeda’s Velcade, melphalan and prednisone (VMP) reduced the risk of death by 40% in the phase 3 ALCYONE trial. But disease progression had already occurred in half of patients on the Darzalex-VMP combo after about three years of follow-up, a much shorter period than the five-year mark the Darzalex-Rd regimen is approaching.